Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cyclosporine 0.05% Eye Drops”

15 trials

Showing 15 of 15 results

Early research (Phase 1)Study completedNCT05353101
What this trial is testing

Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial

Who this might be right for
Vernal KeratoconjunctivitisCyclosporine 0.05% Eye Drops
Second Affiliated Hospital of Nanchang University 48
Post-approval studies (Phase 4)UnknownNCT06043908
What this trial is testing

The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye

Who this might be right for
Dry Eye
Peking University Third Hospital 60
Post-approval studies (Phase 4)Study completedNCT01488396
What this trial is testing

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

Who this might be right for
Stevens-Johnson Syndrome
Mahidol University 31
Large-scale testing (Phase 3)Study completedNCT03865888
What this trial is testing

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

Who this might be right for
Dry EyeSjogren Syndrome
Pavly Moawd 60
Not applicableEnrolling By InvitationNCT07171710
What this trial is testing

Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom

Who this might be right for
Dry Eye Disease
Tianjin Eye Hospital 30
Post-approval studies (Phase 4)Study completedNCT05294666
What this trial is testing

Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

Who this might be right for
Graft Versus Host Disease in Eye
Peking University Third Hospital 89
Not applicableStudy completedNCT05771012
What this trial is testing

Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.

Who this might be right for
Management of Punctal Stenosis
Farwaniya Hospital 42
Not applicableUnknownNCT05131152
What this trial is testing

Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye

Who this might be right for
Dry Eye
Zhongshan Ophthalmic Center, Sun Yat-sen University 100
Not applicableStudy completedNCT06981104
What this trial is testing

Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT

Who this might be right for
Dry Eye Disease (DED)Asthenopia
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Not applicableStudy completedNCT06013436
What this trial is testing

AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With SS Dry Eye

Who this might be right for
Sjogren's SyndromeDry EyeOcular Surface Disease
Chengdu University of Traditional Chinese Medicine 30
Not applicableStudy completedNCT00405431
What this trial is testing

Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?

Who this might be right for
Glaucoma
Wills Eye 43
Post-approval studies (Phase 4)Study completedNCT06824844
What this trial is testing

The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease

Who this might be right for
Dry Eye
Peking University Third Hospital 60
Post-approval studies (Phase 4)Study completedNCT03666884
What this trial is testing

The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome

Who this might be right for
Dry Eye Syndrome
Seref istek 36
Post-approval studies (Phase 4)Study completedNCT05720715
What this trial is testing

Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis

Who this might be right for
Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis
Farwaniya Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT00824811
What this trial is testing

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

Who this might be right for
Epiphora
M.D. Anderson Cancer Center

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation